Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs ; volume:13 ; number:1 ; day:8 ; month:7 ; year:2023 ; pages:1-8 ; date:12.2023
EJNMMI Research ; 13, Heft 1 (8.7.2023), 1-8, 12.2023
- Creator
-
Holzleitner, Nadine
Günther, Thomas
Daoud-Gadieh, Amira
Lapa, Constantin
Wester, Hans-Jürgen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-023-01016-y
- URN
-
urn:nbn:de:101:1-2023101209015378240310
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Holzleitner, Nadine
- Günther, Thomas
- Daoud-Gadieh, Amira
- Lapa, Constantin
- Wester, Hans-Jürgen
- SpringerLink (Online service)
Other Objects (12)
CXCR4-directed theranostics in oncology and inflammation
Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?
Exciting opportunities in nuclear medicine imaging and therapy
Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?
Structural modifications of PSMA ligands to optimize their pharmacokinetics
Development of PSMA inhibitors for molecular imaging and radio-guided surgery of prostate cancer
Development of cyclic pentapeptide ligands for chemokine receptor targeting
Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies
The role of IGFR-L1 in insulin signalling of pancreatic beta-cells and hormone-dependent cancers
CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66
Novel <sup>18</sup>F-labeled Radiopharmaceuticals comprising Silicon-based Fluoride Acceptors
Preclinical evaluation of [68Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [68Ga]pentixafor
CXCR4-directed theranostics in oncology and inflammation
Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?
Exciting opportunities in nuclear medicine imaging and therapy
Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?
Structural modifications of PSMA ligands to optimize their pharmacokinetics
Development of PSMA inhibitors for molecular imaging and radio-guided surgery of prostate cancer
Development of cyclic pentapeptide ligands for chemokine receptor targeting
Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies
The role of IGFR-L1 in insulin signalling of pancreatic beta-cells and hormone-dependent cancers
CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66
Novel <sup>18</sup>F-labeled Radiopharmaceuticals comprising Silicon-based Fluoride Acceptors
Preclinical evaluation of [68Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [68Ga]pentixafor
CXCR4-directed theranostics in oncology and inflammation
Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?
Exciting opportunities in nuclear medicine imaging and therapy
Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?
Structural modifications of PSMA ligands to optimize their pharmacokinetics
Development of PSMA inhibitors for molecular imaging and radio-guided surgery of prostate cancer
Development of cyclic pentapeptide ligands for chemokine receptor targeting
Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies
The role of IGFR-L1 in insulin signalling of pancreatic beta-cells and hormone-dependent cancers
CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66
Novel <sup>18</sup>F-labeled Radiopharmaceuticals comprising Silicon-based Fluoride Acceptors